Prostate cancer metastatic
Clinical trials for Prostate cancer metastatic explained in plain language.
Never miss a new study
Get alerted when new Prostate cancer metastatic trials appear
Sign up with your email to follow new studies for Prostate cancer metastatic, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Hard-to-Treat prostate cancer
Disease control Stopped earlyThis study looked at a combination of two drugs, talazoparib and temozolomide, in 16 men with advanced prostate cancer that had spread and stopped responding to hormone therapy. The goal was to find the safest dose and see if the drugs could shrink tumors. The study was completed…
Matched conditions: PROSTATE CANCER METASTATIC
Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a lower dose of prostate cancer drug work just as well?
Disease control Stopped earlyThis study looked at whether men with prostate cancer could take a lower dose of the drug abiraterone (combined with prednisone) and still control their cancer. About 50 men who had never taken abiraterone before were enrolled. The goal was to find the smallest dose that still lo…
Matched conditions: PROSTATE CANCER METASTATIC
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New pill for advanced prostate cancer shows early promise, but trial halted
Disease control Stopped earlyThis study tested an oral drug called LAE001 in 33 men with metastatic prostate cancer that had stopped responding to standard hormone therapy. The goal was to check safety and find the right dose, and to see if the drug could lower PSA levels. The trial was terminated early, so …
Matched conditions: PROSTATE CANCER METASTATIC
Phase 1/2 • Sponsor: Laekna Limited • Aim: Disease control
Last updated Jun 26, 2026 15:36 UTC